Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Bladder Cancer Surveillance, BCG Unresponsive

Felix Bhatt

MD

🏢Cleveland Clinic🌐USA

Urologic Oncologist

22
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Felix Bhatt has contributed to bladder cancer treatment research, particularly BCG-unresponsive non-muscle invasive bladder cancer — a challenging population where disease persists or recurs after adequate BCG immunotherapy. Novel intravesical therapies including nadofaragene firadenovec (intravesical adenovirus vector expressing interferon alpha-2b) and pembrolizumab have received FDA approval for BCG-unresponsive NMIBC, addressing an important unmet need in this population.

Share:

🧪Research Fields 研究领域

BCG unresponsive bladder cancer
nadofaragene firadenovec bladder
intravesical therapy NMIBC
cystoscopy bladder surveillance
bladder cancer recurrence

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Felix Bhatt 的研究动态

Follow Felix Bhatt's research updates

留下邮箱,当我们发布与 Felix Bhatt(Cleveland Clinic)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment